KADIAN 30 mg (Morphine Sulfate Extended Release 30 mg)

Pill with imprint KADIAN 30 mg is Purple, Capsule-shape and has been identified as Morphine Sulfate Extended Release 30 mg. It is supplied by Actavis.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for KADIAN 30 mg

Morphine sulfate extended release 30 mg KADIAN 30 mg

Morphine Sulfate Extended Release

Imprint: KADIAN 30 mg
Strength: 30 mg
Color: Purple
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Narcotic analgesics
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: 2 - High potential for abuse
Labeler / Supplier: Actavis
Inactive Ingredients: hypromelloses, ethylcellulose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, diethyl phthalate, magnesium silicate, corn starch, sucrose, gelatin, silicon dioxide, sodium lauryl sulfate, titanium dioxide, FD&C Red No. 3, FD&C Blue No. 1, shellac, ferrosoferric oxide, potassium hydroxide, propylene glycol
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00228-3503	Actavis Pharma, Inc.
49884-0834 (Discontinued)	Par Pharmaceutical, Inc.
52544-0032 (Discontinued)	Watson Pharmaceuticals, Inc.
54868-4981 (Discontinued)	Physicians Total Care Inc. (repackager)
35356-0049 (Discontinued)	Lake Erie Medical and Surgical Supply (repackager)
68071-0345	Nucare Pharmaceuticals Inc. (repackager)